Literature DB >> 12388602

Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis.

Kristin E Larsen1, Edward A Fon, Teresa G Hastings, Robert H Edwards, David Sulzer.   

Abstract

Methamphetamine (METH) selectively injures the neurites of dopamine (DA) neurons, generally without inducing cell death. It has been proposed that METH-induced redistribution of DA from the vesicular storage pool to the cytoplasm, where DA can oxidize to produce quinones and additional reactive oxygen species, may account for this selective neurotoxicity. To test this hypothesis, we used mice heterozygous (+/-) or homozygous (-/-) for the brain vesicular monoamine uptake transporter VMAT2, which mediates the accumulation of cytosolic DA into synaptic vesicles. In postnatal ventral midbrain neuronal cultures derived from these mice, METH-induced degeneration of DA neurites and accumulation of oxyradicals, including metabolites of oxidized DA, varied inversely with VMAT2 expression. METH administration also promoted the synthesis of DA via upregulation of tyrosine hydroxylase activity, resulting in an elevation of cytosolic DA even in the absence of vesicular sequestration. Electron microscopy and fluorescent labeling confirmed that METH promoted the formation of autophagic granules, particularly in neuronal varicosities and, ultimately, within cell bodies of dopaminergic neurons. Therefore, we propose that METH neurotoxicity results from the induction of a specific cellular pathway that is activated when DA cannot be effectively sequestered in synaptic vesicles, thereby producing oxyradical stress, autophagy, and neurite degeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388602      PMCID: PMC6757693     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  58 in total

1.  Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size.

Authors:  E N Pothos; K E Larsen; D E Krantz; Y Liu; J W Haycock; W Setlik; M D Gershon; R H Edwards; D Sulzer
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

2.  Nomifensine attenuates d-amphetamine-induced dopamine terminal neurotoxicity in the striatum of rats.

Authors:  F J Wan; I S Shiah; H C Lin; S Y Huang; C S Tung
Journal:  Chin J Physiol       Date:  2000-06-30       Impact factor: 1.764

3.  Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells.

Authors:  M L Mundorf; S E Hochstetler; R M Wightman
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

4.  Dopamine neuronal transport kinetics and effects of amphetamine.

Authors:  S R Jones; J D Joseph; L S Barak; M G Caron; R M Wightman
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

5.  Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice.

Authors:  F Fumagalli; R R Gainetdinov; Y M Wang; K J Valenzano; G W Miller; M G Caron
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

6.  Hydroxyl radical formation following methamphetamine administration to rats.

Authors:  T Kita; M Takahashi; K Kubo; G C Wagner; T Nakashima
Journal:  Pharmacol Toxicol       Date:  1999-09

7.  The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity.

Authors:  J Lotharius; K L O'Malley
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

Review 8.  Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.

Authors:  A E Fleckenstein; J W Gibb; G R Hanson
Journal:  Eur J Pharmacol       Date:  2000-10-06       Impact factor: 4.432

9.  Evidence for free radical formation during the oxidation of 2'-7'-dichlorofluorescin to the fluorescent dye 2'-7'-dichlorofluorescein by horseradish peroxidase: possible implications for oxidative stress measurements.

Authors:  C Rota; C F Chignell; R P Mason
Journal:  Free Radic Biol Med       Date:  1999-10       Impact factor: 7.376

10.  Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

Authors:  D Sulzer; J Bogulavsky; K E Larsen; G Behr; E Karatekin; M H Kleinman; N Turro; D Krantz; R H Edwards; L A Greene; L Zecca
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

View more
  127 in total

1.  The effect of a novel VMAT2 inhibitor, GZ-793A, on methamphetamine reward in rats.

Authors:  Joshua S Beckmann; Emily D Denehy; Guangrong Zheng; Peter A Crooks; Linda P Dwoskin; Michael T Bardo
Journal:  Psychopharmacology (Berl)       Date:  2011-09-21       Impact factor: 4.530

Review 2.  Axon degeneration in Parkinson's disease.

Authors:  Robert E Burke; Karen O'Malley
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

Review 3.  HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.

Authors:  Peter S Silverstein; Ankit Shah; James Weemhoff; Santosh Kumar; D P Singh; Anil Kumar
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

Review 4.  The pathology roadmap in Parkinson disease.

Authors:  D James Surmeier; David Sulzer
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

5.  Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells.

Authors:  Madhavan P N Nair; Zainulabedin M Saiyed; Narayanan Nair; Nimisha H Gandhi; Jose W Rodriguez; Nawal Boukli; Elias Provencio-Vasquez; Robert M Malow; Maria Jose Miguez-Burbano
Journal:  J Neuroimmune Pharmacol       Date:  2008-10-29       Impact factor: 4.147

Review 6.  Role of Autophagy in HIV Pathogenesis and Drug Abuse.

Authors:  Lu Cao; Alexey Glazyrin; Santosh Kumar; Anil Kumar
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

7.  Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease.

Authors:  Antonio Valencia; Ellen Sapp; Jeffrey S Kimm; Hollis McClory; Patrick B Reeves; Jonathan Alexander; Kwadwo A Ansong; Nicholas Masso; Matthew P Frosch; Kimberly B Kegel; Xueyi Li; Marian DiFiglia
Journal:  Hum Mol Genet       Date:  2012-12-07       Impact factor: 6.150

Review 8.  Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications.

Authors:  Annette E Fleckenstein; Trent J Volz; Glen R Hanson
Journal:  Neuropharmacology       Date:  2008-07-10       Impact factor: 5.250

Review 9.  Norepinephrine and stimulant addiction.

Authors:  Mehmet Sofuoglu; R Andrew Sewell
Journal:  Addict Biol       Date:  2008-09-22       Impact factor: 4.280

10.  Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicity.

Authors:  Donald M Kuhn; Dina M Francescutti-Verbeem; David M Thomas
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.